Recent news on Sodium Oxybate

Sleep: A Comprehensive Handbook  -  Apr 17, 2007
Journal of American Medical Association (subscription),Chapter 26, discussing specific pharmacological treatments of sleepiness, such as modafinil, methylphenidate, and sodium oxybate, could have included

Jazz Pharmaceuticals provides information on its latest news and ...  -  Apr 12, 2007
Therapeutics Daily (subscription) (press release),Report 1: Jazz Pharmaceuticals, Inc., announced the signing of an agreement licensing Canadian marketing rights for Xyrem (sodium oxybate) to Valeant

International Approvals: Symbicort SMART, Alimta, Xyrem  -  Mar 19, 2007
Medscape (subscription)The European Commission has approved a new indication for sodium oxybate oral solution in the treatment of narcolepsy with cataplexy in adults.

New European Approval for Xyrem(R) Provides Significant Advance in ...  -  Mar 13, 2007
PipelineReview.com (press release),BRUSSLES, Belgium | Mar 12, 2007 | The European Commission has approved Xyrem(R) (sodium oxybate) for the treatment of narcolepsy with cataplexy in adult

New European Approval for Xyrem(R) Provides Significant Advance in ...  -  Mar 12, 2007
SYS-CON Media,Xyrem® is contraindicated in patients with hypersensitivity to sodium oxybate or to any of the excipients, in patients with succinic semialdehyde

New European Approval For Xyrem® Provides Significant Advance In ...  -  Mar 12, 2007
Medical News Today (press release),The European Commission has approved Xyrem® (sodium oxybate) for the treatment of narcolepsy with cataplexy in adult patients. This new indication means

UCB gets new European approval for Xyrem  -  Mar 14, 2007
Pharma Times (subscription),The European Commission has approved Xyrem (sodium oxybate) for the treatment of narcolepsy with cataplexy in adults and the company noted that the drug is

European Medicines Agency Adopts Positive Opinion Recommending ...  -  Jan 27, 2007
Medical News Today (press release),Sodium oxybate is contraindicated in patients with succinic semialdehyde dehydrogenase deficiency. Sodium oxybate is contraindicated in patients being

Valeant Pharmaceuticals signs licensing pact for Canadian rights ...  -  Feb 8, 2007
Therapeutics Daily (subscription) (press release),Xyrem, a liquid formulation of sodium oxybate, is the first product approved in Canada to treat cataplexy, which is a sudden loss of muscle tone associated

Valeant Pharmaceuticals Signs Licensing Agreement for Canadian ...  -  Jan 12, 2007
PharmaLive.com (press release),Xyrem, a liquid formulation of sodium oxybate, is the first and only product approved in Canada to treat cataplexy, which is a sudden loss of muscle tone

The mother who faints if she says: I love you  -  Jan 4, 2007
Daily Mail,..."There is no cure but judging by the results so far sodium oxybate could certainly help control and manage narcolepsy," she said.

Jazz Pharmaceuticals Signs Licensing Agreement With Valeant ...  -  Jan 12, 2007
PharmaLive.com (press release),...today announced the signing of an agreement licensing Canadian marketing rights for Xyrem(R) (sodium oxybate) to Valeant Pharmaceuticals International .

Jazz Pharmaceuticals Signs Licensing Agreement With Valeant ...  -  Jan 12, 2007
Yahoo! News (press release)12 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. today announced the signing of an agreement licensing Canadian marketing rights for Xyrem® (sodium oxybate) to

Jazz Pharmaceuticals Signs Licensing Agreement With Valeant ...  -  Jan 12, 2007
Earthtimes.org12 -- Jazz Pharmaceuticals, Inc. today announced the signing of an agreement licensing Canadian marketing rights for Xyrem(R) (sodium oxybate) to Valeant

Loving grandma avoids collapse by becoming 'bit of a cold fish'  -  Jan 5, 2007
Yorkshire Post Today,A drug, sodium oxybate, or Xyrem, has now been licensed to treat it but so far she has been unable to persuade her health care trust to fund it.

Woman paralysed by saying I love you  -  Jan 4, 2007
Metro,She is trying to secure NHS funding for a new drug, sodium oxybate, which doctors believe could help her. The drug, marketed as Xyrem, has just been

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)Sodium oxybate is another name for -hydroxybutyrate, also known as GHB. Although this compound is widely know as a drug of abuse, it has been approved by

Volunteers Needed for Stanford Study of Potential Alternative to ...  Oct 17, 2006
The drug, sodium oxybate, is used to treat some symptoms of narcolepsy, a neurological disorder marked by a sudden, uncontrollable urge to sleep. ... -PharmaLive.com (press release), New Study In Journal SLEEP Finds Effective Treatment For ...  Sep 6, 2006
Taking sodium oxybate at night can significantly improve narcoleptics' quality of life, enhance their ability to be productive during the day and provide them ... -Medical News Today

Jazz Pharmaceuticals Announces Phase III Clinical Trial to Study ...  Sep 8, 2006
...announced today the initiation of a Phase III clinical trial intended to evaluate the safety and efficacy of Xyrem® (sodium oxybate) oral solution as a ... -PipelineReview.com

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)Sodium oxybate is another name for -hydroxybutyrate, also known as GHB. Although this compound is widely know as a drug of abuse, it has been approved by



Jazz launches Xyrem for new narcolepsy indication  Mar 7, 2006
The FDA approved Xyrem (sodium oxybate) in July 2002 as the first and only treatment for cataplexy in patients with narcolepsy. ... - Pharmaceutical Business Review



Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain in ...  Feb 23, 2006
23 /PRNewswire/ -- Patients with fibromyalgia syndrome taking Xyrem(R) (sodium oxybate) in a Phase II clinical trial experienced significant pain relief ... - PR Newswire,

Xyrem helps fibromyalgia pain -- study  Feb 23, 2006
SAN DIEGO, Feb. 23 (UPI) -- The drug Xyrem (sodium oxybate) shows promise in relieving pain in patients with a chronic condition called fibromyalgia. ... - United Press International

Xyrem Helps Fibromyalgia Pain -- Study  Feb 23, 2006
The drug Xyrem (sodium oxybate) shows promise in relieving pain in patients with a chronic condition called fibromyalgia. An eight ... - International News Service,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional